DermTech EBITDA 2017-2024 | DMTKQ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

DermTech ebitda from 2017 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

DermTech ebitda from 2017 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$96B
Cencora (COR)	$46.2B
DiDi Global (DIDIY)	$23.8B
ICON (ICLR)	$18.2B
Natera (NTRA)	$15.4B
Avantor (AVTR)	$15.2B
Revvity (RVTY)	$14.9B
Viatris (VTRS)	$13.9B
BioMerieux (BMXMF)	$12.8B
Solventum (SOLV)	$12.5B
CochLear (CHEOY)	$12.3B
Medpace Holdings (MEDP)	$9.9B
Charles River Laboratories (CRL)	$9.3B
Sonic Healthcare (SKHHY)	$8.4B
Doximity (DOCS)	$7.9B
HealthEquity (HQY)	$7.5B
Bausch + Lomb (BLCO)	$7.2B
PACS (PACS)	$6.5B
Life Times (LTH)	$4.7B
Organon (OGN)	$4.7B
Sotera Health (SHC)	$4.5B
Surgery Partners (SGRY)	$3.7B
BrightSpring Health Services (BTSG)	$3B
Concentras Parent (CON)	$2.5B
Ardent Health Partners (ARDT)	$2.5B
Alignment Healthcare (ALHC)	$2.5B
GoodRx Holdings (GDRX)	$2.3B
GeneDx Holdings (WGS)	$2.1B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$1.9B